Vanguard Capital Management
IART icon

Vanguard Capital Management’s Integra LifeSciences IART Stock Holding History

Vanguard Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.9M Buy
2,946,173
+55,349
+2% +$774K ﹤0.01% 1915
2026
Q1 		$27.2M Buy
+2,890,824
New +$31.7M ﹤0.01% 2178

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management's IART Position: Q2 2026 in Review

Vanguard Capital Management increased its Integra LifeSciences (IART) stake by 1.9% in Q2 2026, buying an estimated $774K and bringing the position to 2,946,173 shares worth $52.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1915.

Vanguard Capital Management first reported a position in IART in Q1 2026 and has held it in 2 quarters since. 211 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Vanguard Capital Management held 2,946,173 shares of Integra LifeSciences worth $52.9M as of Q2 2026.
  • Vanguard Capital Management bought 55,349 Integra LifeSciences shares in Q2 2026, an estimated $774K.
  • Integra LifeSciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1915 holding.
  • Vanguard Capital Management first reported a position in Integra LifeSciences in Q1 2026 and has held it in 2 quarters since.
  • 211 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.